Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04685499
Title Phase 2 Study of OBP-301 (Telomelysin) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST